In light of recent wins for mRNA vaccine makers, UCSC RNA Center Co-Director Jeremy Sanford describes the versatility of the ...

Merck and Moderna's success with the Cancer Vaccine paves the way for future advancements in personalized cancer therapy.

The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.

The new mRNA vaccine provides more protection than the standard flu shot.

Share on Pinterest Moderna’s new mRNA flu vaccine has been approved by the FDA for adults ages 50 years and older. FatCamera, E+/Getty Images The Food and Drug Administration (FDA) has approved ...

A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of the first made with the same mRNA technology that was key to ending the ...

A personalized cancer vaccine that identifies and attacks cancer cells unique to each patient has proven effective in a large ...

New Delhi: The US Food and Drug Administration (FDA) last week approved the world’s first flu vaccine developed using messenger RNA (mRNA) technology by American pharmaceutical company Moderna, months ...